Showing 1 - 1 results of 1 for search 'Sariah Kell', query time: 0.02s Refine Results
  1. 1
    609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies

    609 Phase 1/2a dose selection of 23ME-00610, a first-in-class anti-CD200R1 antibody, in patients with advanced solid malignancies by Maike Schmidt, Sariah Kell, Dylan M Glatt, Sophia R Majeed

    Published 2023-11-01
    Article

Search Tools: